Dawn Pope

Chief Operating Officer

Dawn Pope is a clinical research professional with over 20 years in the protection of research participants. As a purpose-driven leader, she has spent her career building high-functioning teams, implementing strategic plans to elevate organizational performance, and delivering innovative solutions to strengthen client relationships. She has extensive experience in operations, client relations, continuous improvement methodologies, and regulatory compliance. She is passionate about operational efficiencies that help bring new therapies to patients sooner. Dawn earned her bachelor’s degree in English from Campbell University in North Carolina. In her free time, you can find her reading, at the beach, traveling with her husband and two children, and attending games of the various sports her children play.

Back to our Team

Get in touch with us to discuss IBC services for your clinical trials.

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.